Article 1
Open βThe Annex to Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Source
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Article 2
Open βThis Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
Supplementary provisions
ANNEXSupplementary provisions
Open βANNEX The Annex to Regulation (EU) No 540/2011 is amended as follows: Part A is amended as follows: (1) In the sixth column, expiration of approval, of entry 311, quinmerac, the date 30 April 2024 is replaced by31 July 2024. (2) In the sixth column, expiration of approval, of entry 314, zinc phosphide, the date 30 April 2024 is replaced by31 July 2024. (3) In the sixth column, expiration of approval, of entry 317, 6-benzyladenine, the date 31 May 2024 is replaced by 31 August 2024. (4) In the sixth column, expiration of approval, of entry 323, dodine, the date 31 May 2024 is replaced by 31 August 2024. (5) In the sixth column, expiration of approval, of entry 328, tau-fluvalinate, the date 31 May 2024 is replaced by 31 August 2024. (6) In the sixth column, expiration of approval, of entry 330, bupirimate, the date 31 May 2024 is replaced by 31 August 2024. (7) In the sixth column, expiration of approval, of entry 333, 1-decanol, the date 31 May 2024 is replaced by 31 August 2024. (8) In the sixth column, expiration of approval, of entry 334, isoxaben, the date 31 May 2024 is replaced by 31 August 2024. (9) In the sixth column, expiration of approval, of entry 335, fluometuron, the date 31 May 2024 is replaced by 31 August 2024. (10) In the sixth column, expiration of approval, of entry 341, sintofen, the date 31 May 2024 is replaced by 31 August 2024. (11) In the sixth column, expiration of approval, of entry 343, azadirachtin, the date 31 May 2024 is replaced by 31 August 2024. (12) In the sixth column, expiration of approval, of entry 345, lime sulphur, the date 31 May 2024 is replaced by 31 August 2024. (13) In the sixth column, expiration of approval, of entry 346, aluminium sulfate, the date 31 May 2024 is replaced by 31 August 2024. (14) In the sixth column, expiration of approval, of entry 350, tebufenozide, the date 31 May 2024 is replaced by 31 August 2024. (15) In the sixth column, expiration of approval, of entry 351, dithianon, the date 31 May 2024 is replaced by 31 August 2024. (16) In the sixth column, expiration of approval, of entry 352, hexythiazox, the date 31 May 2024 is replaced by 31 August 2024. (17) In the sixth column, expiration of approval, of entry 353, flutriafol, the date 31 May 2024 is replaced by 31 August 2024. Part B is amended as follows: (1) In the sixth column, expiration of approval, of entry 24, fluxapyroxad, the date 31 December 2022 is replaced by 31 May 2025. (2) In the sixth column, expiration of approval, of entry 26, Adoxophyes orana granulovirus , the date 31 January 2023 is replaced by 31 January 2024. (3) In the sixth column, expiration of approval, of entry 37, C andid a oleophila strain O, the date 30 September 2023 is replaced by 31 December 2024. (4) In the sixth column, expiration of approval, of entry 39, Paecilomyces fumosoroseus strain FE 9901, the date 30 September 2023 is replaced by 31 December 2024. (5) In the sixth column, expiration of approval, of entry 40, potassium phosphonates, the date 30 September 2023 is replaced by 31 January 2026. (6) In the sixth column, expiration of approval, of entry 43, bixafen, the date 30 September 2023 is replaced by 31 May 2025. (7) In the sixth column, expiration of approval, of entry 48 , sedaxane, the date 31 January 2024 is replaced by 31 May 2025. (8) In the sixth column, expiration of approval, of entry 49, emamectin, the date 30 April 2024 is replaced by 30 November 2024. (9) In the sixth column, expiration of approval, of entry 50, Pseudomonas sp . strain DSMZ 13134, the date 31 January 2024 is replaced by 31 January 2025. (10) In the sixth column, expiration of approval, of entry 52 , Aureobasidium pullulans (strains DSM 14940 and DSM 14941), the date 31 January 2024 is replaced by 31 January 2025. (11) In the sixth column, expiration of approval, of entry 53 , pyriofenone, the date 31 January 2024 is replaced by 31 January 2025. (12) In the sixth column, expiration of approval, of entry 54 , disodium phosphonate, the date 31 January 2024 is replaced by 31 January 2026. (13) In the sixth column, expiration of approval, of entry 55 , penflufen, the date 31 January 2024 is replaced by 31 May 2025. (14) In the sixth column, expiration of approval, of entry 56, orange oil, the date 30 April 2024 is replaced by 31 July 2024. (15) In the sixth column, expiration of approval, of entry 57, penthiopyrad, the date 30 April 2024 is replaced by 31 May 2025. (16) In the sixth column, expiration of approval, of entry 58, benalaxyl-M, the date 30 April 2024 is replaced by 30 April 2025. (17) In the sixth column, expiration of approval, of entry 59, tembotrione, the date 30 April 2024 is replaced by 31 July 2024. (18) In the sixth column, expiration of approval, of entry 60, spirotetramat, the date 30 April 2024 is replaced by 31 July 2024. (19) In the sixth column, expiration of approval, of entry 61, pyroxsulam, the date 30 April 2024 is replaced by 30 April 2025. (20) In the sixth column, expiration of approval, of entry 62, chlorantraniliprole, the date 30 April 2024 is replaced by 31 December 2024. (21) In the sixth column, expiration of approval, of entry 63, sodium silver thiosulfate, the date 30 April 2024 is replaced by 31 July 2024. (22) In the sixth column, expiration of approval, of entry 64, pyridalyl, the date 30 June 2024 is replaced by 30 June 2025. (23) In the sixth column, expiration of approval, of entry 68, 1,4-dimethylnaphthalene, the date 30 June 2024 is replaced by 30 June 2025. (24) In the sixth column, expiration of approval, of entry 69, amisulbrom, the date 30 June 2024 is replaced by 30 September 2024. (25) In the sixth column, expiration of approval, of entry 65, S-abscisic acid, the date 30 June 2024 is replaced by 30 September 2024. (26) In the sixth column, expiration of approval, of entry 66, L-ascorbic acid, the date 30 June 2024 is replaced by 30 September 2024. (27) In the sixth column, expiration of approval, of entry 67, spinetoram, the date 30 June 2024 is replaced by 30 September 2024. (28) In the sixth column, expiration of approval, of entry 70, valifenalate, the date 30 June 2024 is replaced by 30 September 2024. (29) In the sixth column, expiration of approval, of entry 71, thiencarbazone, the date 30 June 2024 is replaced by 30 September 2024. (30) In the sixth column, expiration of approval, of entry 72, acequinocyl, the date 31 August 2024 is replaced by 30 November 2024. (31) In the sixth column, expiration of approval, of entry 73, ipconazole, the date 31 August 2024 is replaced by 30 November 2024. (32) In the sixth column, expiration of approval, of entry 74, flubendiamide, the date 31 August 2024 is replaced by 30 November 2024. (33) In the sixth column, expiration of approval, of entry 75, Bacillus pumilus QST 2808, the date 31 August 2024 is replaced by 31 August 2025. (34) In the sixth column, expiration of approval, of entry 79, Streptomyces lydicus strain WYEC 108, the date 31 December 2024 is replaced by 31 December 2025. Part E is amended as follows: (1) In the sixth column, expiration of approval, of entry 6, prosulfuron, the date 30 April 2024 is replaced by 31 July 2024. (2) In the sixth column, expiration of approval, of entry 7, pendimethalin, the date 31 August 2024 is replaced by 30 November 2024. (3) In the sixth column, expiration of approval, of entry 8, imazamox, the date 31 October 2024 is replaced by 31 January 2025.
Other acts of the same type
Commission Implementing Regulation (EU) 2015/1013 of 25 June 2015 laying down rules in respect of Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and of Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/1014 of 25 June 2015 amending Regulation (EC) No 474/2006 establishing the Community list of air carriers which are subject to an operating ban within the Community (Text with EEA relevance)Regulation (EU) 2015/1017 of the European Parliament and of the Council of 25 June 2015 on the European Fund for Strategic Investments, the European Investment Advisory Hub and the European Investment Project Portal and amending Regulations (EU) No 1291/2013 and (EU) No 1316/2013 β the European Fund for Strategic InvestmentsCommission Implementing Regulation (EU) 2015/983 of 24 June 2015 on the procedure for issuance of the European Professional Card and the application of the alert mechanism pursuant to Directive 2005/36/EC of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/984 of 24 June 2015 approving copper pyrithione as an existing active substance for use in biocidal products for product-type 21 (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/985 of 24 June 2015 approving clothianidin as an existing active substance for use in biocidal products for product-type 18 (Text with EEA relevance)Commission Implementing Regulation (EU) 2015/1004 of 24 June 2015 amending Regulation (EC) No 1484/95 as regards fixing representative prices in the poultrymeat and egg sectors and for egg albuminCommission Delegated Regulation (EU) 2015/1538 of 23 June 2015 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council with regard to import licence applications, release for free circulation and proof of refining of sugar products of CN code 1701 under preferential agreements, for the marketing years 2015/16 and 2016/17 and amending Commission Regulations (EC) No 376/2008 and (EC) No 891/2009Council Implementing Regulation (EU) 2015/961 of 22 June 2015 implementing Regulation (EU) No 36/2012 concerning restrictive measures in view of the situation in SyriaCommission Implementing Regulation (EU) 2015/1003 of 22 June 2015 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (Saint-Nectaire (PDO))Commission Implementing Regulation (EU) 2015/949 of 19 June 2015 approving the pre-export checks carried out on certain food by certain third countries as regards the presence of certain mycotoxins (Text with EEA relevance)Council Regulation (EU) 2015/960 of 19 June 2015 amending Regulation (EU) 2015/104 as regards certain fishing opportunities
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview